Connect with us

Top Penny Stocks to Watch on Robinhood In August 2021

Looking for Robinhood penny stocks to watch in August? Check these 3 out for your list
The post Top Penny Stocks to Watch on Robinhood In August 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Published

on

Are These Robinhood Penny Stocks Worth Watching Right Now?

With August speeding by, many investors are searching for the best penny stocks to buy. And right now, there are plenty of factors that are impacting the overall trajectory of the market. With penny stocks, the key to making a profit is understanding how events will shift certain industries or specific stocks. And in 2021, there are quite a few to consider. 

The most important of these remains the pandemic. While it initially began as a detriment to the market, quickly, investors found new ways to profit. And a year and a half after it started, those ways have changed slightly, and new methods have been added in. 

Many penny stocks investors are focusing on a few industries in specific right now. This includes tech, biotech, EV penny stocks, energy stocks, and more. While this is not a complete list of penny stocks that could benefit from the pandemic, these are a few industries that should remain on your watchlist. And when we add in the volatility that Robinhood offers, we see even more penny stocks that could be worth watching.

[Read More] Best Biotech Penny Stocks For Your Monday Watchlist

In addition to this, investors also have to consider the effects of the over $1 trillion package making its way through the government right now. This could have a large impact on several industries and should be worth keeping an eye on. So, with all of this in mind, let’s take a look at some of the top Robinhood penny stocks to watch as August turns the corner. 

3 Hot Penny Stocks to Watch Right Now 

  1. Ebang International Holdings Inc. (NASDAQ: EBON
  2. Atossa Therapeutics Inc. (NASDAQ: ATOS
  3. Dare Bioscience Inc. (NASDAQ: DARE

Ebang International Holdings Inc. (NASDAQ: EBON)

Ebang International Holdings Inc. is a tech penny stock that researches, designs, and develops app-specific integrated circuit chips. The company also manufactures Bitcoin mining machines in China, the U.S., and Hong Kong. Its products are sold under the Ebit and EBANG brand names. Over the past year, the popularity of Bitcoin has risen substantially. 

[Read More] Could These Penny Stocks Benefit From the Infrastructure Bill?

And, companies that work in the blockchain or crypto industry respectively, have both seen heightened investor interest. While the recent Chinese regulations surrounding Bitcoin mining did hurt shares of EBON stock, shares seem to have corrected in the right direction since then. 

In addition to the popularity of Bitcoin, other crypto-assets such as DogeCoin and Ethereum have also risen in value substantially. And we also have to consider the positivity around blockchain-related assets such as NFTs. All of this serves to benefit Ebang International because of its Bitcoin mining machine manufacturing business. 

It’s also worth noting that when Bitcoin performs well, EBON can see correlative momentum as a result. EBON has not released any recent updates, but its volume is strong in recent trading sessions. With all of this in mind, is EBON a contender for your list of penny stocks to watch?

Atossa Therapeutics Inc. (NASDAQ: ATOS)

Atossa Therapeutics Inc. is a biotech company working on the discovery and development of new medicines for oncology and infectious diseases. One of its main products is Endoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. The company is also working on AT-301 drug candidate meant to treat those with COVID-19.

[Read More] Top Penny Stocks to Watch As Jobs Report Shows Signs of Growth

Any company involved in a Covid treatment is one that has seen heightened interest in the past few months. And while Atossa has not yet received approval for this product to be sold commercially, it is working hard to do so. In July, Atossa received approval to open a clinical study of AT-H201 in Australia. AT-H201 is an inhalation therapy for hospitalized COVID-19 patients. 

“If the initial parts of the study are successful we will study the efficacy of our proprietary AT-H201 on moderately ill COVID-19 patients who can be treated via a nebulizer. Our goal in developing nebulized AT-H201 is to improve lung function in patients with active disease, which may reduce the number of patients requiring ventilators and in “long-haul” patients who have residual pulmonary function damage.” 

The CEO and President of Atossa, Steven Quay

While this product is still in the testing stages, it could be a breakthrough for an otherwise unmet area of treating Covid. Keeping this in mind, is ATOS stock making your list of penny stocks to watch?

Penny_Stocks_to_Watch_Atossa_Therapeutics_Inc_ATOS_Stock_Chart

Dare Bioscience Inc. (NASDAQ: DARE)

Another biotech penny stock that is trending right now is Dare Bioscience Inc. This is a company that develops therapies for contraception, fertility, sexual, and personal health. The company’s DARE-HRT1 product is for treating vasomotor symptoms in hormone therapy. Dare has a wide variety of other products in trials for women’s health as well. 

On July 12th, the company announced a collaborative research agreement for the Phase 3 study of Ovaprene. Ovaprene is a hormone-free monthly contraceptive that is in an investigational state right now. While this may seem like a niche area of the biotech industry, there is a lot of unmet needs in the women’s health industry.

“We are thrilled to continue our work with NICHD to advance Ovaprene® through this pivotal study. Grant funding previously provided by NICHD supported the conduct of our pre-pivotal clinical study of Ovaprene. With this CRADA, we have the opportunity to leverage NICHD’s experience in the design and execution of contraceptive studies, as well as continued funding to support the development of Ovaprene.” 

President and CEO of Dare, Sabrina Martucci Johnson

Collaborative research agreements in the biotech industry are one of the most popular ways that companies grow. And because of this, we could see Dare move forward with Ovaprene in the near future. Considering all of this, will DARE stock be on your list of penny stocks to watch? 

Penny_Stocks_to_Watch_Dare_Bioscience_Inc_DARE_Stock_Chart

Which Robinhood Penny Stocks Are You Watching in August 2021?

Finding the best penny stocks to buy on Robinhood in August is all about understanding where the market is moving. With so many factors occurring simultaneously, it can be difficult to keep up with everything at once.

[Read More] 5 Best Penny Stocks To Buy Right Now According To Insiders

However, with a commitment to research and gaining a trading education, finding the best penny stocks to buy for your watchlist can be easy. Considering all of this, which penny stocks are you watching in August 2021?

The post Top Penny Stocks to Watch on Robinhood In August 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Read More

Continue Reading

Government

Low Iron Levels In Blood Could Trigger Long COVID: Study

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate…

Published

on

Low Iron Levels In Blood Could Trigger Long COVID: Study

Authored by Amie Dahnke via The Epoch Times (emphasis ours),

People with inadequate iron levels in their blood due to a COVID-19 infection could be at greater risk of long COVID.

(Shutterstock)

A new study indicates that problems with iron levels in the bloodstream likely trigger chronic inflammation and other conditions associated with the post-COVID phenomenon. The findings, published on March 1 in Nature Immunology, could offer new ways to treat or prevent the condition.

Long COVID Patients Have Low Iron Levels

Researchers at the University of Cambridge pinpointed low iron as a potential link to long-COVID symptoms thanks to a study they initiated shortly after the start of the pandemic. They recruited people who tested positive for the virus to provide blood samples for analysis over a year, which allowed the researchers to look for post-infection changes in the blood. The researchers looked at 214 samples and found that 45 percent of patients reported symptoms of long COVID that lasted between three and 10 months.

In analyzing the blood samples, the research team noticed that people experiencing long COVID had low iron levels, contributing to anemia and low red blood cell production, just two weeks after they were diagnosed with COVID-19. This was true for patients regardless of age, sex, or the initial severity of their infection.

According to one of the study co-authors, the removal of iron from the bloodstream is a natural process and defense mechanism of the body.

But it can jeopardize a person’s recovery.

When the body has an infection, it responds by removing iron from the bloodstream. This protects us from potentially lethal bacteria that capture the iron in the bloodstream and grow rapidly. It’s an evolutionary response that redistributes iron in the body, and the blood plasma becomes an iron desert,” University of Oxford professor Hal Drakesmith said in a press release. “However, if this goes on for a long time, there is less iron for red blood cells, so oxygen is transported less efficiently affecting metabolism and energy production, and for white blood cells, which need iron to work properly. The protective mechanism ends up becoming a problem.”

The research team believes that consistently low iron levels could explain why individuals with long COVID continue to experience fatigue and difficulty exercising. As such, the researchers suggested iron supplementation to help regulate and prevent the often debilitating symptoms associated with long COVID.

It isn’t necessarily the case that individuals don’t have enough iron in their body, it’s just that it’s trapped in the wrong place,” Aimee Hanson, a postdoctoral researcher at the University of Cambridge who worked on the study, said in the press release. “What we need is a way to remobilize the iron and pull it back into the bloodstream, where it becomes more useful to the red blood cells.”

The research team pointed out that iron supplementation isn’t always straightforward. Achieving the right level of iron varies from person to person. Too much iron can cause stomach issues, ranging from constipation, nausea, and abdominal pain to gastritis and gastric lesions.

1 in 5 Still Affected by Long COVID

COVID-19 has affected nearly 40 percent of Americans, with one in five of those still suffering from symptoms of long COVID, according to the U.S. Centers for Disease Control and Prevention (CDC). Long COVID is marked by health issues that continue at least four weeks after an individual was initially diagnosed with COVID-19. Symptoms can last for days, weeks, months, or years and may include fatigue, cough or chest pain, headache, brain fog, depression or anxiety, digestive issues, and joint or muscle pain.

Tyler Durden Sat, 03/09/2024 - 12:50

Read More

Continue Reading

Uncategorized

February Employment Situation

By Paul Gomme and Peter Rupert The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000…

Published

on

By Paul Gomme and Peter Rupert

The establishment data from the BLS showed a 275,000 increase in payroll employment for February, outpacing the 230,000 average over the previous 12 months. The payroll data for January and December were revised down by a total of 167,000. The private sector added 223,000 new jobs, the largest gain since May of last year.

Temporary help services employment continues a steep decline after a sharp post-pandemic rise.

Average hours of work increased from 34.2 to 34.3. The increase, along with the 223,000 private employment increase led to a hefty increase in total hours of 5.6% at an annualized rate, also the largest increase since May of last year.

The establishment report, once again, beat “expectations;” the WSJ survey of economists was 198,000. Other than the downward revisions, mentioned above, another bit of negative news was a smallish increase in wage growth, from $34.52 to $34.57.

The household survey shows that the labor force increased 150,000, a drop in employment of 184,000 and an increase in the number of unemployed persons of 334,000. The labor force participation rate held steady at 62.5, the employment to population ratio decreased from 60.2 to 60.1 and the unemployment rate increased from 3.66 to 3.86. Remember that the unemployment rate is the number of unemployed relative to the labor force (the number employed plus the number unemployed). Consequently, the unemployment rate can go up if the number of unemployed rises holding fixed the labor force, or if the labor force shrinks holding the number unemployed unchanged. An increase in the unemployment rate is not necessarily a bad thing: it may reflect a strong labor market drawing “marginally attached” individuals from outside the labor force. Indeed, there was a 96,000 decline in those workers.

Earlier in the week, the BLS announced JOLTS (Job Openings and Labor Turnover Survey) data for January. There isn’t much to report here as the job openings changed little at 8.9 million, the number of hires and total separations were little changed at 5.7 million and 5.3 million, respectively.

As has been the case for the last couple of years, the number of job openings remains higher than the number of unemployed persons.

Also earlier in the week the BLS announced that productivity increased 3.2% in the 4th quarter with output rising 3.5% and hours of work rising 0.3%.

The bottom line is that the labor market continues its surprisingly (to some) strong performance, once again proving stronger than many had expected. This strength makes it difficult to justify any interest rate cuts soon, particularly given the recent inflation spike.

Read More

Continue Reading

Spread & Containment

Another beloved brewery files Chapter 11 bankruptcy

The beer industry has been devastated by covid, changing tastes, and maybe fallout from the Bud Light scandal.

Published

on

Before the covid pandemic, craft beer was having a moment. Most cities had multiple breweries and taprooms with some having so many that people put together the brewery version of a pub crawl.

It was a period where beer snobbery ruled the day and it was not uncommon to hear bar patrons discuss the makeup of the beer the beer they were drinking. This boom period always seemed destined for failure, or at least a retraction as many markets seemed to have more craft breweries than they could support.

Related: Fast-food chain closes more stores after Chapter 11 bankruptcy

The pandemic, however, hastened that downfall. Many of these local and regional craft breweries counted on in-person sales to drive their business. 

And while many had local and regional distribution, selling through a third party comes with much lower margins. Direct sales drove their business and the pandemic forced many breweries to shut down their taprooms during the period where social distancing rules were in effect.

During those months the breweries still had rent and employees to pay while little money was coming in. That led to a number of popular beermakers including San Francisco's nationally-known Anchor Brewing as well as many regional favorites including Chicago’s Metropolitan Brewing, New Jersey’s Flying Fish, Denver’s Joyride Brewing, Tampa’s Zydeco Brew Werks, and Cleveland’s Terrestrial Brewing filing bankruptcy.

Some of these brands hope to survive, but others, including Anchor Brewing, fell into Chapter 7 liquidation. Now, another domino has fallen as a popular regional brewery has filed for Chapter 11 bankruptcy protection.

Overall beer sales have fallen.

Image source: Shutterstock

Covid is not the only reason for brewery bankruptcies

While covid deserves some of the blame for brewery failures, it's not the only reason why so many have filed for bankruptcy protection. Overall beer sales have fallen driven by younger people embracing non-alcoholic cocktails, and the rise in popularity of non-beer alcoholic offerings,

Beer sales have fallen to their lowest levels since 1999 and some industry analysts

"Sales declined by more than 5% in the first nine months of the year, dragged down not only by the backlash and boycotts against Anheuser-Busch-owned Bud Light but the changing habits of younger drinkers," according to data from Beer Marketer’s Insights published by the New York Post.

Bud Light parent Anheuser Busch InBev (BUD) faced massive boycotts after it partnered with transgender social media influencer Dylan Mulvaney. It was a very small partnership but it led to a right-wing backlash spurred on by Kid Rock, who posted a video on social media where he chastised the company before shooting up cases of Bud Light with an automatic weapon.

Another brewery files Chapter 11 bankruptcy

Gizmo Brew Works, which does business under the name Roth Brewing Company LLC, filed for Chapter 11 bankruptcy protection on March 8. In its filing, the company checked the box that indicates that its debts are less than $7.5 million and it chooses to proceed under Subchapter V of Chapter 11. 

"Both small business and subchapter V cases are treated differently than a traditional chapter 11 case primarily due to accelerated deadlines and the speed with which the plan is confirmed," USCourts.gov explained. 

Roth Brewing/Gizmo Brew Works shared that it has 50-99 creditors and assets $100,000 and $500,000. The filing noted that the company does expect to have funds available for unsecured creditors. 

The popular brewery operates three taprooms and sells its beer to go at those locations.

"Join us at Gizmo Brew Works Craft Brewery and Taprooms located in Raleigh, Durham, and Chapel Hill, North Carolina. Find us for entertainment, live music, food trucks, beer specials, and most importantly, great-tasting craft beer by Gizmo Brew Works," the company shared on its website.

The company estimates that it has between $1 and $10 million in liabilities (a broad range as the bankruptcy form does not provide a space to be more specific).

Gizmo Brew Works/Roth Brewing did not share a reorganization or funding plan in its bankruptcy filing. An email request for comment sent through the company's contact page was not immediately returned.

 

Read More

Continue Reading

Trending